HPLC Analysis of Plasma Glipizide and its Application to Pharmacokinetic Study

REFERENCES

• Wensing , G. Glipizide: An oral hypoglycemic drug . Am. J. Med. Sci. 1989 , 298 , 69 – 71 .
   Google Scholar
• Glipizide (Glucotrol®) prescribing information. Pfizer Inc., NY, USA. 2000. Available at: http://www.pfizer.com/pfizer/download/uspi_glucotrol.pdf
   Google Scholar
• Wåhlin-Boll , E. ; Melander , A. High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum . J. Chromatogr. 1979 , 164 , 541 – 546 .
   PubMed Web of Science ®Google Scholar
• Emilsson , H. High-performance liquid chromatographic determination of glipizide in human plasma and urine . J. Chromatogr. 1987 , 421 , 319 – 326 .
   PubMed Web of Science ®Google Scholar
• Starkey , B.J. ; Mould , G.P. ; Teale , J.D. The determination of sulphonylurea drugs by HPLC and its clinical application . J. Liq. Chromatogr. 1989 , 12 , 1889 – 1896 .
   Google Scholar
• Shenfield , G.M. ; Boutagy , J.S. ; Webb , C. A screening test for detecting sulfonylureas in plasma . Ther. Drug. Monit. 1990 , 12 , 393 – 397 .
   Google Scholar
• Dhawan , S. ; Singla , A.K. Performance liquid chromatographic analysis of glipizide: Application to in vitro and in vivo studies. J. Chromatogr. Sci. 2003, 41, 295–300.
   PubMed Web of Science ®Google Scholar
• Lee , Y.J. ; Kim , Y.G. ; Lee , M.G. ; Chung , S.J. ; Lee , M.H. ; Shim , C.K. Analysis of bioequivalence study using log-transformed model . Yakhakhoeji. 2000 , 44 , 308 – 314 .
   Google Scholar
• Jönsson , A. ; Chan , J.C. ; Rydberg , T. ; Vaaler , S. ; Hallengren , B. ; Cockram , C.S. ; Critchley , J.A. ; Melander , A. Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes . Eur. J. Clin. Pharmacol. 2000 , 56 , 711 – 714 .
   Google Scholar
• Kidd , R.S. ; Straughn , A.B. ; Meyer , M.C. ; Blaisdell , J. ; Goldstein , J.A. ; Dalton , J.T. Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9∗3 allele . Pharmacogenetics. 1999 , 9 , 71 – 80 .
   PubMedGoogle Scholar
• Melander , A. Clinical pharmacology of sulfonylureas . Metabolism. 1987 , 36 ( 2 Suppl. 1 ), 12 – 16 .
   PubMed Web of Science ®Google Scholar
• Wåhlin-Boll , E. ; Almer , L.O. ; Melander , A. Bioavailability pharmacokinetics and effects of glipizide in type 2 diabetics . Clin. Pharmacokinet. 1982 , 7 , 363 – 372 .
   PubMed Web of Science ®Google Scholar
• Kradjan , W.A. ; Kobayashi , K.A. ; Bauer , L.A. ; Horn , J.R. ; Opheim , K.E. ; Wood , Jr. , F.J. Glipizide pharmacokinetics: Effects of age, diabetes, and multiple dosing . J. Clin. Pharmacol. 1989 , 29 , 1121 – 1127 .
   PubMed Web of Science ®Google Scholar
• Dhawan , S. ; Singh , B. ; Garg , S.K. ; Hota , D. ; Dash , R.J. ; Singla , A.K. ; Sinha , V.R. Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers . Clin. Pharmacokinet. 2006 , 45 , 317 – 324 .
   PubMed Web of Science ®Google Scholar
• Kobayashi , K.A. ; Bauer , L.A. ; Horn , J.R. ; Opheim , K. ; Wood , Jr. , F. Kradjan , W.A. Glipizide pharmacokinetics in young and elderly volunteers . Clin. Pharm. 1988 , 7 , 224 – 228 .
   Google Scholar
• Jaber , L.A. ; Ducharme , M.P. ; Halapy , H. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus . Ther. Drug. Monit. 1996 , 18 , 6 – 13 .
   Google Scholar